Found 116 matching trials
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Show More Learn More & Join Trial
Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia PHASE2 RATIONALE: Vorinostat may stop the growth of cancer cells by interfering wi...
Show More Location
Stanford University
Learn More & Join Trial
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML PHASE3 MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Show More Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Learn More & Join Trial
Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia PHASE4 The purpose of this study is to evaluate the effect of corticosteroids on t...
Show More Location
Multiple Locations
Learn More & Join Trial
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia PHASE2 This phase II trial is studying the side effects of giving azacitidine toge...
Show More Status
Active Not Recruiting
Location
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Learn More & Join Trial
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE2 RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin N/A RATIONALE: Studying samples of DNA from patients receiving gemtuzumab ozoga...
Show More Location
Multiple Locations
Learn More & Join Trial
Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia PHASE2 RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate t...
Show More Location
Genta Incorporated
Learn More & Join Trial
Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia PHASE1 This is a prospective, single-center phase 1 clinical study aimed at determ...
Show More Location
Froedtert Hospital & the Medical College of Wisconsin
Learn More & Join Trial
Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS PHASE2 The purpose of this study is to find out how safe and effective the combina...
Show More Location
Weill Medcial College of Cornell University
Learn More & Join Trial